Literature DB >> 11944752

Fibrinolytic therapy for acute ST-segment elevation myocardial infarction.

Anthony Kerigan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11944752      PMCID： PMC99441     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Thrombolytic therapy in the elderly.

Authors:  H D White
Journal:  Lancet       Date:  2000-12-16       Impact factor: 79.321

2.  Modern doctoring.

Authors:  R C McGouran
Journal:  J R Coll Physicians Lond       Date:  2000 Nov-Dec

Review 3.  New advances in the management of acute coronary syndromes: 2. Fibrinolytic therapy for acute ST-segment elevation myocardial infarction.

Authors:  P W Armstrong
Journal:  CMAJ       Date:  2001-09-18       Impact factor: 8.262

Review 4.  Thrombolytics in elderly patients: a triumph of hope over experience?

Authors:  D R Thiemann; S P Schulman
Journal:  CMAJ       Date:  2001-05-01       Impact factor: 8.262

5.  Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years.

Authors:  D R Thiemann; J Coresh; S P Schulman; G Gerstenblith; W J Oetgen; N R Powe
Journal:  Circulation       Date:  2000-05-16       Impact factor: 29.690

Review 6.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.